169 related articles for article (PubMed ID: 12432424)
21. White superficial onychomycosis of a toenail due to Microsporum canis.
Lee HJ; Ha SJ; Lee SJ; Kim JW; Cho BK
Acta Derm Venereol; 2000; 80(2):155. PubMed ID: 10877147
[No Abstract] [Full Text] [Related]
22. Onychomycosis due to Aspergillus tamarii in a 3-year-old boy.
Kristensen L; Stenderup J; Otkjaer A
Acta Derm Venereol; 2005; 85(3):261-2. PubMed ID: 16040417
[No Abstract] [Full Text] [Related]
23. Superficial white onychomycosis revisited.
Baran R; Hay R; Perrin C
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):569-71. PubMed ID: 15324395
[TBL] [Abstract][Full Text] [Related]
24. Response to "A financial perspective on the topical treatment of onychomycosis".
Elewski BE
J Am Acad Dermatol; 2016 Jul; 75(1):e39. PubMed ID: 27317545
[No Abstract] [Full Text] [Related]
25. [Onychomycosis].
Sato T
Med Mycol J; 2016; 57(4):J171-J173. PubMed ID: 27904063
[No Abstract] [Full Text] [Related]
26. Clinical practice. Fungal nail disease.
de Berker D
N Engl J Med; 2009 May; 360(20):2108-16. PubMed ID: 19439745
[No Abstract] [Full Text] [Related]
27. Management of toe onychomycosis: what is the potential for improving efficacy of treatment?
Gupta AK
Clin Dermatol; 2002; 20(5):607-9. PubMed ID: 12435532
[No Abstract] [Full Text] [Related]
28. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Shemer A; Nathansohn N; Kaplan B; Trau H
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
[TBL] [Abstract][Full Text] [Related]
29. Onychomycosis: rationalization of topical treatment.
Shemer A; Trau H; Davidovici B; Amichai B; Grunwald MH
Isr Med Assoc J; 2008 Jun; 10(6):415-6. PubMed ID: 18669135
[TBL] [Abstract][Full Text] [Related]
30. [Common fungal infections of the foot].
Gheeraert P
Rev Med Brux; 2006 Sep; 27(4):S324-6. PubMed ID: 17091897
[TBL] [Abstract][Full Text] [Related]
31. Observer agreement in toenail disorders: implications for diagnosis and clinical research.
Ginarte M; Garcia-Doval I; Monteagudo B; Cabanillas M; Labandeira J; Florez A; Cabo F; Alvarez J; Zulaica A; Allegue F; Pérez L; Abalde MT; Rosón E; de la Torre C; Rodríguez MX
Br J Dermatol; 2009 Jun; 160(6):1315-7. PubMed ID: 19239464
[TBL] [Abstract][Full Text] [Related]
32. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of onychomycoses with terbinafine (Lamisil)].
Baudraz F; Rakosi T
Rev Med Suisse Romande; 1998 Nov; 118(11):975-9. PubMed ID: 9865129
[No Abstract] [Full Text] [Related]
34. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
35. [How to improve efficacy of onychomycosis treatment?].
Nowicki R
Wiad Parazytol; 2001; 47(4):823-32. PubMed ID: 16886434
[TBL] [Abstract][Full Text] [Related]
36. Nondermatophytes. Pathogen or distracter in onychomycosis.
Lagana FJ
Clin Podiatr Med Surg; 1995 Apr; 12(2):255-62. PubMed ID: 7600499
[TBL] [Abstract][Full Text] [Related]
37. The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine.
Zaias N; Rebell G
Arch Dermatol; 2004 Jun; 140(6):691-5. PubMed ID: 15210459
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
Tausch I; Bräutigam M; Weidinger G; Jones TC
Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Piraccini BM; Sisti A; Tosti A
J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with presence and severity of toenail onychomycosis in patients with diabetes: a cross-sectional study.
Takehara K; Oe M; Tsunemi Y; Nagase T; Ohashi Y; Iizaka S; Ueki K; Tsukamoto K; Kadowaki T; Sanada H
Int J Nurs Stud; 2011 Sep; 48(9):1101-8. PubMed ID: 21367414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
